Syndax Pharmaceuticals Inc (SNDX) earnings · rev $172.4M
These earnings events as JSON? API free 100/daySyndax Pharmaceuticals Inc (SNDX) is a biotechnology company listed on US.
This SNDX earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported SNDX revenue for 2025-12-31 was $172.4M. Net income was -$285.4M. Revenue was up 627.8% from 2024-12-31 to 2025-12-31. SNDX currently screens at market cap $774.4M.
When the next SNDX 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 627.8% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full SNDX research stays on the stock page; the tape stays on the quote page.
SNDX earnings FAQ
What are SNDX's latest revenue and net income?
Latest cached Syndax Pharmaceuticals Inc (SNDX) revenue for Dec 31, 2025 was $172.4M. Net income was -$285.4M. Statements: https://lician.com/financials/sndx
What is SNDX's latest diluted EPS?
Latest cached Syndax Pharmaceuticals Inc (SNDX) diluted EPS for Dec 31, 2025 was -$3.29.
What period does the latest SNDX earnings print cover?
The latest cached Syndax Pharmaceuticals Inc (SNDX) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did SNDX revenue change from the prior cached period?
Cached Syndax Pharmaceuticals Inc (SNDX) revenue was up 627.8% from $23.7M (Dec 31, 2024) to $172.4M (Dec 31, 2025). Statements: https://lician.com/financials/sndx
Where are SNDX earnings listed?
Cached earnings facts for Syndax Pharmaceuticals Inc (SNDX) are listed at https://lician.com/earnings/sndx. Statements: https://lician.com/financials/sndx
Not investment advice.